1. Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011; 9. 365(11):993–1003. PMID:
21899409.
2. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005; 3. 352(13):1305–1316. PMID:
15800226.
Article
3. Henkes H, Miloslavski E, Lowens S, Reinartz J, Liebig T, Kühne D. Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self-expanding stent deployment (WingSpan). Neuroradiology. 2005; 3. 47(3):222–228. PMID:
15912418.
Article
4. Jiang WJ, Srivastava T, Gao F, Du B, Dong KH, Xu XT. Perforator stroke after elective stenting of symptomatic intracranial stenosis. Neurology. 2006; 6. 66(12):1868–1872. PMID:
16801652.
Article
5. Leung TW, Yu SC, Lam WW, Chan AY, Lau AY, Wong LK. Would self-expanding stent occlude middle cerebral artery perforators? Stroke. 2009; 5. 40(5):1910–1912. PMID:
19182082.
Article
6. Levy EI, Chaturvedi S. Perforator stroke following intracranial stenting: a sacrifice for the greater good. Neurology. 2006; 6. 66(12):1803–1804. PMID:
16801640.
Article
7. Lopes DK, Ringer AJ, Boulos AS, Qureshi AI, Lieber BB, Guterman LR, et al. Fate of branch arteries after intracranial stenting. Neurosurgery. 2003; 6. 52(6):1275–1278. discussion 1278-9. PMID:
12762872.
Article
8. Masuo O, Terada T, Walker G, Tsuura M, Nakai K, Itakura T. Patency of perforating arteries after stent placement? A study using an in vivo experimental atherosclerosis-induced model. Am J Neuroradiol. 2005; 3. 26(3):543–548. PMID:
15760863.
9. Nahab F, Cotsonis G, Lynn M, Feldmann E, Chaturvedi S, Hemphill JC, et al. Prevalence and prognosis of coexistent asymptomatic intracranial stenosis. Stroke. 2008; 3. 39(3):1039–1041. PMID:
18239161.
Article
10. Nahab F, Lynn MJ, Kasner SE, Alexander MJ, Klucznik R, Zaidat OO, et al. Risk factors associated with major cerebrovascular complications after intracranial stenting. Neurology. 2009; 6. 72(23):2014–2019. PMID:
19299309.
Article
11. Poerner TC, Kralev S, Voelker W, Sueselbeck T, Latsch A, Pfleger S, et al. Natural history of small and medium-sized side branches after coronary stent implantation. Am Heart J. 2002; 4. 143(4):627–635. PMID:
11923799.
Article
12. Sacco RL, Kargman DE, Gu Q, Zamanillo MC. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke. 1995; 1. 26(1):14–20. PMID:
7839388.
13. Schumacher HC, Khaw AV, Myers PM, Gupta R, Higashida RT. Intracranial angioplasty and stent placement for cerebral atherosclerosis. J Vasc Interv Radiol. 2004; 1. 15(1 Pt 2):S123–S132. PMID:
15101521.
Article
14. Umont TM, Sonig A, Mokin M, Eller JL, Sorkin GC, Snyder KV, et al. Submaximal angioplasty for symptomatic intracranial atherosclerosis: a prospective Phase I study. J Neurosurg. 2016; 10. 125(4):964–971. PMID:
26745485.
15. Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators. Design, progress and challenges of a double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis. Neuroepidemiology. 2003; Mar-Apr. 22(2):106–117. PMID:
12656117.
16. Wong KS, Li H, Lam WW, Chan YL, Kay R. Progression of middle cerebral artery occlusive disease and its relationship with further vascular events after stroke. Stroke. 2002; 2. 33(2):532–536. PMID:
11823665.
Article
17. Wong LKS. Global burden of intracranial atherosclerosis. Int J Stroke. 2006; 8. 1(3):158–159. PMID:
18706036.
Article